| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-01 | Lorrain Daniel S. Chief Scientific Officer | Sale | -4,170 | -2.91%139,372 | $13.16 | $54,862 | View SEC filing | |
| 2026-05-01 | Lorrain Daniel S. Chief Scientific Officer | Sale | -4,170 | -2.82%143,542 | $13.12 | $54,694 | View SEC filing | |
| 2026-04-06 | Lorrain Daniel S. Chief Scientific Officer | Sale | -4,170 | -2.75%147,712 | $13.43 | $56,014 | View SEC filing | |
| 2026-03-02 | Lorrain Daniel S. Chief Scientific Officer | Sale | -4,170 | -2.67%151,882 | $15.01 | $62,585 | View SEC filing | |
| 2026-03-02 | Watkins Tim CMO & Head of Development | Sale | -3,611 | -100.00%0 | $15.02 | $54,220 | View SEC filing | |
| 2026-02-26 | Stengone Carmine N. CEO and President | Sale | -7,100 | -22.73%14,954 | $16.02 | $113,728 | View SEC filing | |
| 2026-02-26 | Lorrain Daniel S. Chief Scientific Officer | Sale | -8,124 | -2.68%156,052 | $16.02 | $130,164 | View SEC filing | |
| 2026-02-20 | Lorrain Daniel S. Chief Scientific Officer | Sale | -100 | -0.06%156,052 | $16.00 | $1,600 | View SEC filing | |
| 2026-02-13 | Stengone Carmine N. CEO and President | Sale | -400 | -2.61%14,954 | $16.00 | $6,400 | View SEC filing | |
| 2026-02-13 | Lorrain Daniel S. Chief Scientific Officer | Sale | -400 | -0.26%156,052 | $16.00 | $6,400 | View SEC filing | |
| 2026-02-05 | Lorrain Daniel S. Chief Scientific Officer | Sale | -4,170 | -2.60%156,052 | $14.94 | $62,305 | View SEC filing | |
| 2026-01-30 | Watkins Tim CMO & Head of Development | Sale | -3,611 | -100.00%0 | $14.18 | $51,188 | View SEC filing | |
| 2026-01-06 | Lorrain Daniel S. Chief Scientific Officer | Sale | -4,170 | -2.54%160,222 | $10.44 | $43,543 | View SEC filing | |
| 2025-12-30 | Watkins Tim CMO & Head of Development | Sale | -3,611 | -100.00%0 | $12.06 | $43,558 | View SEC filing | |
| 2025-12-30 | Lorrain Daniel S. Chief Scientific Officer | Sale | -4,170 | -2.47%164,392 | $12.23 | $51,009 | View SEC filing | |
| 2024-11-27 | Lorrain Daniel S. Chief Scientific Officer | Sale | -1,010 | -0.60%168,562 | $16.02 | $16,177 | View SEC filing | |
| 2024-11-20 | Lorrain Daniel S. Chief Scientific Officer | Sale | -6,190 | -3.52%169,572 | $16.38 | $101,421 | View SEC filing |
1-17 of 17